Trump Promotes Medicaid Drug Price Reduction Program Ahead of Midterms

Ahead of the midterm elections, President Trump announced that all states have joined a program aimed at aligning Medicaid drug prices with those of other wealthy countries. This initiative seeks to reduce the cost of medicines under Medicaid nationwide. The announcement highlights a significant policy effort to address drug pricing in the U.S.

Originally published by nyt